CATALOGO DEI PRODOTTI DELLA RICERCA

MICHELETTO, CLAUDIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.458
NA - Nord America 2.335
AS - Asia 1.642
SA - Sud America 211
AF - Africa 60
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.715
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.279
RU - Federazione Russa 945
SG - Singapore 703
IT - Italia 488
CN - Cina 415
GB - Regno Unito 399
BR - Brasile 169
VN - Vietnam 154
HK - Hong Kong 147
DE - Germania 114
FR - Francia 106
SE - Svezia 103
IE - Irlanda 81
FI - Finlandia 64
KR - Corea 45
PL - Polonia 43
IN - India 41
JP - Giappone 34
CA - Canada 33
ZA - Sudafrica 23
UA - Ucraina 20
ID - Indonesia 19
MX - Messico 17
NL - Olanda 17
ES - Italia 16
BE - Belgio 13
SA - Arabia Saudita 13
TR - Turchia 13
AR - Argentina 12
AT - Austria 11
LT - Lituania 10
BD - Bangladesh 9
EC - Ecuador 9
MY - Malesia 9
NG - Nigeria 7
TG - Togo 7
AU - Australia 6
BJ - Benin 6
IQ - Iraq 6
PY - Paraguay 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
PK - Pakistan 5
TN - Tunisia 5
CL - Cile 4
CZ - Repubblica Ceca 4
PE - Perù 4
RO - Romania 4
UZ - Uzbekistan 4
VE - Venezuela 4
BG - Bulgaria 3
CH - Svizzera 3
HU - Ungheria 3
IL - Israele 3
MA - Marocco 3
PH - Filippine 3
AL - Albania 2
CO - Colombia 2
DO - Repubblica Dominicana 2
EG - Egitto 2
HR - Croazia 2
JM - Giamaica 2
LB - Libano 2
LV - Lettonia 2
NP - Nepal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
DK - Danimarca 1
DM - Dominica 1
ET - Etiopia 1
GE - Georgia 1
GH - Ghana 1
HN - Honduras 1
JO - Giordania 1
KE - Kenya 1
LK - Sri Lanka 1
MZ - Mozambico 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PT - Portogallo 1
SN - Senegal 1
TH - Thailandia 1
TZ - Tanzania 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.715
Salva come PNG Salva come JPEG
Città #
Singapore 369
Moscow 364
Ashburn 334
Southend 280
San Jose 264
Chandler 226
Dallas 203
Hong Kong 144
Verona 143
Jacksonville 125
Beijing 86
Dublin 81
The Dalles 81
Redmond 69
New York 60
Ann Arbor 59
Ho Chi Minh City 51
Houston 51
Milan 49
Los Angeles 44
Woodbridge 41
Munich 35
Council Bluffs 33
Hanoi 33
Lawrence 32
Princeton 32
Boardman 29
Rome 28
Tokyo 28
São Paulo 27
Buffalo 25
Jinan 25
Wilmington 25
Helsinki 24
London 23
Sindelfingen 21
Warsaw 19
Bologna 18
Changsha 18
Columbus 17
Nanjing 16
Naples 16
Shenyang 16
Tianjin 16
Da Nang 15
Orem 15
Chennai 14
Jakarta 14
Redondo Beach 14
Seattle 14
Toronto 14
Ningbo 13
Taizhou 13
Frankfurt am Main 12
Johannesburg 12
Zhengzhou 12
Atlanta 11
Brussels 11
Denver 11
Phoenix 11
Turku 11
Manchester 10
Pretoria 10
Santa Clara 10
Turin 10
Brooklyn 9
Chicago 9
Hebei 9
Poplar 9
Amsterdam 8
City of London 8
Falls Church 8
Haikou 8
Haiphong 8
Lanzhou 8
Mexico City 8
Montreal 8
Padua 8
Abuja 7
Guangzhou 7
Kuala Lumpur 7
Lomé 7
Nuremberg 7
San Francisco 7
Taiyuan 7
Vicenza 7
Ankara 6
Brescia 6
City of Westminster 6
Cotonou 6
Fuzhou 6
Jiaxing 6
Kent 6
Lancaster 6
Rio de Janeiro 6
Riyadh 6
Vienna 6
Auburn Hills 5
Baku 5
Barnet 5
Totale 4.182
Salva come PNG Salva come JPEG
Nome #
Dupilumab-induced hypereosinophilia: review of the literature and algorithm proposal for clinical management 434
Cost analysis of GER-induced asthma: a controlled study vs. atopic asthma of comparable severity. 328
A two-stage logistic Model Based on the Measurament of Pro-Infectious Cytokines in Bronchial Secretions for Assessing Bacterial, Viral and Non-Infectious Origin of COPD Exacerbation - Original Research 230
Assessment of COVID-19 progression on day 5 from symptoms onset 214
Diagnostic management of occult nodal lymphangioleiomyomatosis detected during pelvic cancer staging. Localized finding or systemic disease? 200
Long-Term Patient-Centred Follow-up in a Prospective Cohort of Patients with COVID-19 191
A MCh test pre-post esophageal acidification in detecting GER-related asthma. 183
Asthmatic patients in COVID-19 outbreak: Few cases despite many cases 180
Determinants of Persistence of Symptoms and Impact on Physical and Mental Wellbeing in Long COVID: A Prospective Cohort Study 178
Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity 175
Exercise prehabilitation in lung cancer: Getting stronger to recover faster 175
Changes in total IgE plasma concentration measured at the third month during anti-IgE treatment predict future exacerbation rates in difficult-to-treat atopic asthma: a pilot study. 163
Integrating supportive care into the multidisciplinary management of lung cancer: we can't wait any longer 162
Effects of HFA- and CFC-beclomethasone dipropionate on the bronchial response to methacholine (MCh) in mild asthma. 161
How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center 161
Effect of HFA- and CFC-beclomethasone dipropionate on the bronchial response to methacholine (MCh) in mild asthma 160
Antimicrobial Stewardship in COVID-19 Patients: Those Who Sow Will Reap Even through Hard Times 152
COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey 151
Lung metastasis from TTF-1 positive sigmoid adenocarcinoma. pitfalls and management. 145
Low‑dose anti‑IL 5 treatment in idiopathic hypereosinophilic syndrome: towards a precision medicine approach for remission maintenance 144
A Framework For Step Down Or Therapeutic Re-Organization For Withdrawal Of Inhaled Corticosteroids In Selected Patients With COPD: A Proposal For COPD Management 141
Idiopathic hypereosinophilic syndromes and rare dysimmune conditions associated with hyper-eosinophilia in practice: An innovative multidisciplinary approach 138
Molecular predictors of EGFR-mutant NSCLC transformation into LCNEC after frontline osimertinib: digging under the surface 138
Mepolizumab 100 mg in severe asthmatic patients with EGPA in remission phase 136
Mepolizumab for severe eosinophilic asthma: a real-world snapshot on clinical markers and timing of response 132
Reference urinary LTE4 levels in normal individuals: a pilot study. 131
Multidisciplinary management in type 2 inflammatory disease 130
Profiling blood hypereosinophilia in patients on dupilumab treatment for respiratory conditions: a real-life snapshot 129
PATTERN OF AIRWAY INFLAMMATION AND REMODELLING IN MILD PERSISTENT ATOPIC ASTHMA AND IN MILD PERSISTENT ASTHMA RELATED TO GASTROESOPHAGEAL REFLUX 129
PIKO-1, an effective, handy device for the patient's personal PEFR and FEV1 electronic long-term monitoring. 127
ARIA-ITALY multidisciplinary consensus on nasal polyposis and biological treatments 120
Nasal and bronchial tolerability of Rofecoxib in patients with aspirin induced asthma. 119
Omalizumab management beyond clinical trials: the added value of a network model 119
CT radiomic models to distinguish COVID-19 pneumonia from other interstitial pneumonias 114
Vitamin D and disease severity in coronavirus disease 19 (COVID-19) 112
Low adherence to inhaled corticosteroids/long-acting β2-agonists and biologic treatment in severe asthmatics 111
Unlocking the Long-Term Effectiveness of Benralizumab in Severe Eosinophilic Asthma: A Three-Year Real-Life Study 101
Nasal and Bronchial Tolerability of Rofecoxib in Patients with Aspirin induced Asthma 101
Safety of dupilumab in T2 airways conditions: focus on eosinophilia across trials and real-life evidence 99
Dupilumab Efficacy on Asthma Functional, Inflammatory, and Patient-Reported Outcomes across Different Disease Phenotypes and Severity: A Real-Life Perspective 98
Pneumonic versus Nonpneumonic Exacerbations of Chronic Obstructive Pulmonary Disease 86
Reply to "Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose?" 85
Prevalence of asymptomatic SARS-CoV-2-positive individuals in the general population of northern Italy and evaluation of a diagnostic serological ELISA test: a cross-sectional study protocol 80
Latent transition analysis for longitudinal studies of post-acute infection syndromes 79
Organization, Clinical and Management Indicators on the First Year of Activity of an Outpatient Clinic Dedicated to the Diagnosis and Treatment of Severe Asthma in Italy 69
Long-Term Eosinophil Depletion: A Real-World Perspective on the Safety and Durability of Benralizumab Treatment in Severe Eosinophilic Asthma 62
ARIA-Italy multidisciplinary consensus on nasal polyposis and biological treatments: Update 2025 17
Totale 6.790
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.958
article - articoli 20.958
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.916
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202154 0 0 0 0 0 0 0 0 0 19 29 6
2021/2022366 52 113 12 22 8 9 5 22 13 8 25 77
2022/2023628 39 71 56 110 64 120 7 33 73 6 30 19
2023/2024497 27 38 47 47 45 78 26 36 12 28 77 36
2024/20251.158 78 59 48 158 50 48 83 82 185 78 101 188
2025/20263.242 197 149 195 552 902 220 329 235 287 176 0 0
Totale 6.790